|
FBG variability category (CV, %)
|
Total
|
Men
|
Women
|
|---|
|
No. of CVD case/total
|
Lifetime risk% (95%CI)
|
P-value
|
No. of CVD case/total
|
Lifetime risk% (95%CI)
|
P-value
|
No. of CVD case/total
|
Lifetime risk% (95%CI)
|
P-value
|
|---|
|
35 years
|
|
Low (< 6.19)
|
528/15339
|
26.3 (23.0, 29.5)
|
Ref
|
455/11262
|
28.0 (24.5, 31.4)
|
Ref
|
73/4077
|
17.8 (11.3, 24.2)
|
Ref
|
|
Intermediate (6.19–10.86)
|
603/15340
|
28.3 (25.5, 31.1)
|
0.357
|
547/11676
|
30.8 (27.9, 33.8)
|
0.214
|
56/3664
|
13.8 (9.6, 18.1)
|
0.316
|
|
High (> 10.86)
|
758/15339
|
32.5 (28.9, 36.1)
|
0.013
|
688/12124
|
34.7 (30.9, 38.5)
|
0.010
|
70/3215
|
18.1 (10.6, 25.7)
|
0.942
|
|
45 years
|
|
Low (< 6.26)
|
502/12713
|
26.0 (22.8, 29.3)
|
Ref
|
430/9519
|
27.5 (24.1, 31.0)
|
Ref
|
72/3194
|
17.9 (11.5, 24.2)
|
Ref
|
|
Intermediate (6.26%-11.03%)
|
584/12720
|
27.7 (25.0, 30.5)
|
0.443
|
528/9755
|
30.1 (27.2, 33.1)
|
0.269
|
56/2965
|
14.1 (9.9, 18.4)
|
0.335
|
|
High (> 11.03%)
|
704/12716
|
32.1 (28.3, 35.9)
|
0.018
|
638/10042
|
34.4 (30.5, 38.4)
|
0.011
|
66/2674
|
18.0 (9.4, 26.5)
|
0.990
|
|
55 years
|
|
Low (< 6.57%)
|
345/7041
|
24.6 (21.3, 28.0)
|
Ref
|
294/5533
|
25.9 (22.3, 29.5)
|
Ref
|
51/1508
|
16.4 (10.2, 22.5)
|
Ref
|
|
Intermediate (6.57–11.40)
|
408/7042
|
25.6 (22.8, 28.4)
|
0.655
|
364/5505
|
27.6 (24.5, 30.7)
|
0.468
|
44/1537
|
13.5 (9.1, 18.0)
|
0.464
|
|
High (> 11.40)
|
468/7041
|
30.4 (26.3, 34.5)
|
0.032
|
423/5532
|
32.5 (28.2, 36.8)
|
0.020
|
45/1509
|
16.8 (7.8, 25.8)
|
0.937
|
- CVD Cardiovascular diseases, FBG Fasting blood glucose, CV Coefficient of variation
- Lifetime risk estimates represent the percentage of cohort participants who would experience a total CVD event from the index age to the end of follow-up if the last participant in the cohort were to die at the last age of follow-up (95 years)
